Elanco Animal Net Worth
Elanco Animal Net Worth Breakdown | ELAN |
Elanco Animal Net Worth Analysis
Elanco Animal's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Elanco Animal's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Elanco Animal's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Elanco Animal's net worth analysis. One common approach is to calculate Elanco Animal's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Elanco Animal's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Elanco Animal's net worth. This approach calculates the present value of Elanco Animal's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Elanco Animal's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Elanco Animal's net worth. This involves comparing Elanco Animal's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Elanco Animal's net worth relative to its peers.
To determine if Elanco Animal is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Elanco Animal's net worth research are outlined below:
| Elanco Animal Health generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 4.42 B. Net Loss for the year was (1.23 B) with profit before overhead, payroll, taxes, and interest of 2.44 B. | |
| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from gurufocus.com: Elanco Animal Health Inc Launches Pet Protect A New Line of Veterinarian-Formulated Pet ... |
Elanco Animal Quarterly Good Will |
|
Elanco Animal uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Elanco Animal Health. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Elanco Animal's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 20th of February 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 20th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Elanco Animal's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Elanco Animal is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Elanco Animal Health backward and forwards among themselves. Elanco Animal's institutional investor refers to the entity that pools money to purchase Elanco Animal's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Magnetar Financial Llc | 2024-12-31 | 12 M | State Street Corp | 2024-12-31 | 10.4 M | Geode Capital Management, Llc | 2024-12-31 | 8.2 M | Citadel Advisors Llc | 2024-09-30 | 7.5 M | Manufacturers Life Insurance Co | 2024-12-31 | 6.9 M | Brandes Investment Partners & Co | 2024-12-31 | 5.7 M | Charles Schwab Investment Management Inc | 2024-12-31 | 4.7 M | Prudential Financial Inc | 2024-12-31 | 4.2 M | Ubs Group Ag | 2024-12-31 | 4.2 M | Dodge & Cox | 2024-12-31 | 83.2 M | Primecap Management Company | 2024-12-31 | 51.2 M |
Follow Elanco Animal's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 5.29 B.Market Cap |
|
Project Elanco Animal's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.07 | 0.08 | |
| Return On Capital Employed | 0.02 | 0.03 | |
| Return On Assets | 0.03 | 0.03 | |
| Return On Equity | 0.06 | 0.06 |
When accessing Elanco Animal's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Elanco Animal's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Elanco Animal's profitability and make more informed investment decisions.
Evaluate Elanco Animal's management efficiency
Elanco Animal Health has return on total asset (ROA) of 0.0118 % which means that it generated a profit of $0.0118 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0324 %, meaning that it created $0.0324 on every $100 dollars invested by stockholders. Elanco Animal's management efficiency ratios could be used to measure how well Elanco Animal manages its routine affairs as well as how well it operates its assets and liabilities. As of the 26th of February 2025, Return On Tangible Assets is likely to grow to 0.08. Also, Return On Capital Employed is likely to grow to 0.03. At this time, Elanco Animal's Return On Tangible Assets are very stable compared to the past year. As of the 26th of February 2025, Return On Assets is likely to grow to 0.03, while Total Assets are likely to drop about 13.6 B.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 12.34 | 18.06 | |
| Tangible Book Value Per Share | (4.05) | (4.25) | |
| Enterprise Value Over EBITDA | 39.18 | 41.14 | |
| Price Book Value Ratio | 0.98 | 1.68 | |
| Enterprise Value Multiple | 39.18 | 41.14 | |
| Price Fair Value | 0.98 | 1.68 |
Evaluating the management effectiveness of Elanco Animal allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The Elanco Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Enterprise Value Revenue 2.1013 | Revenue | Quarterly Revenue Growth (0.04) | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Elanco Animal insiders, such as employees or executives, is commonly permitted as long as it does not rely on Elanco Animal's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Elanco Animal insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Elanco Animal Corporate Filings
8K | 25th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 21st of February 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 12th of February 2025 Other Reports | ViewVerify | |
F3 | 19th of November 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
Elanco Animal Earnings per Share Projection vs Actual
Elanco Animal Corporate Directors
| Joshua Smiley | Independent Director | Profile | |
| Carl McMillian | Independent Director | Profile | |
| Denise ScotsKnight | Independent Director | Profile | |
| Kirk McDonald | Independent Director | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elanco Animal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Elanco Animal. If investors know Elanco will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Elanco Animal listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.71) | Earnings Share 0.41 | Revenue Per Share | Quarterly Revenue Growth (0.04) | Return On Assets |
The market value of Elanco Animal Health is measured differently than its book value, which is the value of Elanco that is recorded on the company's balance sheet. Investors also form their own opinion of Elanco Animal's value that differs from its market value or its book value, called intrinsic value, which is Elanco Animal's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Elanco Animal's market value can be influenced by many factors that don't directly affect Elanco Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Elanco Animal's value and its price as these two are different measures arrived at by different means. Investors typically determine if Elanco Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Elanco Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.